Evidence map›Paper›PMID 39936280›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

A brain DNA co-methylation network analysis of psychosis in Alzheimer's disease.

Morteza Kouhsar, Luke Weymouth, Adam R Smith, Jennifer Imm, Claudia Bredemeyer, Yehani Wedatilake, Ali Torkamani, Sverre Bergh, Geir Selbæk, Jonathan Mill and 6 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Delineating blood DNA methylation biomarkers for Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. A brain DNA co-methylation network analysis of psychosis in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Morteza KouhsarDepartment of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, Devon, UK.
Luke WeymouthDepartment of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, Devon, UK.
Adam R SmithDepartment of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, Devon, UK.
Jennifer ImmDepartment of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, Devon, UK.
Claudia BredemeyerDepartment of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, Devon, UK.
Yehani WedatilakeNorwegian National Centre for Aging and Health, Vestfold Hospital Trust, Tønsberg, Norway.
Ali TorkamaniThe Scripps Research Institute, La Jolla, California, USA.
Sverre BerghNorwegian National Centre for Aging and Health, Vestfold Hospital Trust, Tønsberg, Norway.
Geir SelbækNorwegian National Centre for Aging and Health, Vestfold Hospital Trust, Tønsberg, Norway.
Jonathan MillDepartment of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, Devon, UK.
Clive BallardDepartment of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, Devon, UK.
Robert A SweetDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Julia KoflerDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Byron CreeseDepartment of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, Devon, UK.
Ehsan PishvaDepartment of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, Devon, UK.
Katie LunnonDepartment of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, Devon, UK.ORCID https://orcid.org/0000-0001-7570-6065

Funding

Research Education ComponentP30AG066468 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI C. Elizabeth Shaaban · 2020 to 2026
$29.4M
Scripps Clinical and Translational Science HubUM1TR004407 · NCATS · SCRIPPS RESEARCH INSTITUTE, THE · PI Eric Jeffrey Topol · 2023 to 2026
$24.2M
Prediction of Psychosis in Alzheimer DiseaseR01AG027224 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SWEET, ROBERT A · 2007 to 2021
$10.8M
Synaptic Resilience to Psychosis in Alzheimer DiseaseR01MH116046 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Julia K Kofler, ROBERT A SWEET · 2018 to 2026
$6.6M
A multi-omic approach to elucidate novel disease mechanisms and biomarkers for psychosis in Alzheimer’s diseaseR01AG067015 · NIA · UNIVERSITY OF EXETER · PI KOFLER, JULIA K, LUNNON, KATIE · 2019 to 2023
$1.6M
National Institute for Health and Care ResearchNCATS NIH HHS UM1 TR004407NCATS NIH HHS UM1TR004407NIA NIH HHS P30 AG066468NIA NIH HHS R01 AG027224NIA NIH HHS R01 AG067015NIH HHS P30AG066468NIH HHS R01AG027224NIH HHS R01AG067015NIMH NIH HHS MH116046NIMH NIH HHS R01 MH116046South-Eastern Norway Regional Health AuthorityZonMw Memorabel/Alzheimer Nederland 733050516
6 · The paper itself

Abstract

introductionThe presence of psychosis in Alzheimer's disease (AD) is suggested to be associated with distinct molecular and neuropathological profiles in the brain.

methodsWe assessed brain DNA methylation in AD donors with psychosis (AD+P) and without psychosis (AD-P) using the EPIC array. Weighted gene correlation network analysis identified modules of co-methylated genes in a discovery cohort (PITT-ADRC: N = 113 AD+P, N = 40 AD-P), with validation in an independent cohort (BDR: N = 79 AD+P, N = 117 AD-P), with Gene Ontology and cell-type enrichment analysis. Genetic data were integrated to identify methylation quantitative trait loci (mQTLs), which were co-localized with GWAS for related traits.

resultsWe replicated one AD+P associated module, which was enriched for synaptic pathways and in excitatory and inhibitory neurons. mQTLs in this module co-localized with variants associated with schizophrenia and educational attainment. DISCUSSION: This represents the largest epigenetic study of AD+P to date, identifying pleiotropic relationships between AD+P and related traits. HIGHLIGHTS: DNA methylation was assessed in the prefrontal cortex in subjects with AD+P and AD-P. WGCNA identified six modules of co-methylated loci associated with AD+P in a discovery cohort. One of the modules was replicated in an independent cohort. This module was enriched for synaptic genes and in excitatory and inhibitory neurons. mQTLs mapping to genes in the module co-localized with GWAS loci for schizophrenia and educational attainment.

Indexed as

Alzheimer DiseaseBrainDNA MethylationPsychotic DisordersAgedAged, 80 and overCohort StudiesFemaleGene Regulatory NetworksGenome-Wide Association StudyHumansMaleQuantitative Trait LociAlzheimer's disease (AD)brainDNA methylationepigeneticsmethylation quantitative trait loci (mQTLs)pathwayspsychosisschizophreniaweighted gene correlation network analysis (WGCNA)

Identifiers

PMID39936280
PMCPMC11815327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.